🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Online First! Tiffany Bellomo Anahita Dua MD MS MBA FACS and colleagues report that popliteal artery aneurysms are often not surveyed at recommended intervals and duplex ultrasound reports frequently lack necessary measurements to make clinical decisions. buff.ly/3U3PASu

Did you miss the incredible #vascular #billing #coding webinar? Well, it’s your lucky day! Check out the #SVM website —> vascularmed.org to access the recording until February 4, 2024! Become a #member to access it anytime! G. Jay Bishop M.D. Cleveland Clinic Vascular Medicine AV

#Perspective Pruthvi C R PCI's evolution from balloon angioplasty to bare metal and drug-eluting stents, bioresorbable scaffolds, and now, DCBs, completes the circle #AHAJournals ahajournals.org/doi/10.1161/CI…

April is Limb Loss Awareness Month! Check out video interviews from last year’s AMP the CLTI Meeting featuring #CLTI experts and be sure to join us this August in Chicago—get $100 off with code AWARENESS until 4/30. #CLIFighters okt.to/H605mc

#SVMer’s are EVERYWHERE! Amazing #DVT #POCUS sessions led by few of our #SVM members at #ACP ACP #IM2024 #IMProud #internalmedicine #bedside #ultrasound Syed T Ahsan Gaurav Parmar Cleveland Clinic Vascular Medicine

From our ‘Core Curriculum in Vascular Medicine’ series: Chronic thromboembolic pulmonary hypertension and the post-pulmonary embolism syndrome. Read this excellent review by Eugene Yuriditsky James Horowitz Joe Lau #VascularTwitter buff.ly/3ECgHvl

Exploring a rare case of Klippel-Trenaunay Syndrome (KTS) with our fellow Sayed Bukhari MD and Ammar Saati عمار ساعاتي While lower limbs are often affected, this case showcases the uniqueness of KTS manifesting in the upper extremity #VascularMedicine

1/ Published today: The updated evidence-based recommendations for managing Lower Extremity PAD, originally outlined in the 2016 Guideline, now incorporate the latest research findings to assist clinicians. ✍🏽:Heather L Gornik 📖: Circulation

#SVM is EXCITED to collaborate w/ The PERT Consortium® for a SPECIAL #WEBINAR: “Evaluating all aspects of #pulmonaryembolism treatment.” 🕰️ When: Tuesday, May 21, 8:00 PM EDT Register now → csavevents.zoom.us/webinar/regist… #PE #bloodclot #PERT kenneth rosenfield Rachel Rosovsky Alison Witkin

Online First! In this study, Stanislav Henkin and colleagues study the impact of the Affordable Care Act Medicaid Expansion on mortality and amputation rates in patients with peripheral artery disease. buff.ly/4cf8I5Q #Peripheralarterydisease #HealthEquity

Are you EXCITED for #VSS2024 ??? Don’t forget to #register and #book your hotel by 8/16 (TODAY) to take advantage of the SVM Special Room Rate at the Marriott Marquis —> veritasamc.us16.list-manage.com/track/click?u=… Elizabeth Ratchford Raghu Kolluri Aditya Sharma Heather L Gornik Stanislav Henkin Esther Kim

We are excited to share #SVM #Medscape #collaboration “Addressing Barriers to Medical management of PAD: Insights from Vascular Medicine Experts” 👏 The program has just been launched and is available on the SVM website (vascularmed.org) for PAD/Vascular Specialists 🙌

#VMJ Editorial Board meeting in Houston! #VSS2024 #VSS24 @SVM_Tweets Heather L Gornik More photos to come

Amazing content - treating vascular diseases require passion, science and implementation - all being discussed here!

🔴🆕The "2024 AHA/ACC/Multisociety Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery"⤵️ 🔹Provides recommendations for perioperative cardiovascular evaluation & management of adult patients undergoing noncardiac surgery. 🔹 bit.ly/4dmNTFQ

Retrospective cohort study finds significant hospital-level variability in GDMT score at HFrEF patient discharge. Higher GDMT score linked to reduced mortality, rehospitalization, and costs, while increasing home time. ja.ma/3ZCXsx5

Have you read our State-of-the-Art Review, "Obstruction in Hypertrophic Cardiomyopathy: Many Faces?" Read the JASE article here: bit.ly/3KqJxl1

Mavacamten was associated with reductions in biomarkers of cardiac wall stress and injury, with no sustained reductions in LVEF observed in patients with HFpEF and LVEF of 60% or greater. ja.ma/4dljU0X #HFSA2024

In this analysis of a pragmatic randomized clinical trial, claims and EHR data provided the most clinical end-point data when compared with participant-reported events. ja.ma/4eQEiZ8